Ragunath Singaravelu

Ragunath Singaravelu is a virologist and cellular biologist with extensive experience in cancer immunology research and viral vector engineering. Prior to Related Sciences, Ragunath worked in the Canadian public health and regulatory sectors. His post-doctoral training includes fellowships in Katherine Fitzgerald's lab at UMassMed, where he studied innate immune signaling, and John Bell's lab at the Ottawa Hospital Research Institute, where he worked on worked on pre-clinical development of novel COVID-19 vaccines and immunotherapies, including IND-enabling studies for an oncolytic virus candidate. Ragunath completed his PhD in Microbiology and Immunology at University of Ottawa.